VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report)’s stock price rose 7.1% on Wednesday . The company traded as high as C$0.15 and last traded at C$0.15. Approximately 107,650 shares changed hands during trading, a decline of 54% from the average daily volume of 232,410 shares. The stock had previously closed at C$0.14.
VentriPoint Diagnostics Stock Performance
The stock’s 50-day moving average price is C$0.14 and its 200 day moving average price is C$0.13. The firm has a market cap of C$24.33 million, a P/E ratio of -4.63 and a beta of 0.39. The company has a debt-to-equity ratio of -58.56, a current ratio of 0.28 and a quick ratio of 6.67.
VentriPoint Diagnostics Company Profile
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.
Read More
- Five stocks we like better than VentriPoint Diagnostics
- What Investors Need to Know About Upcoming IPOs
- Can IBM’s Q1 Earnings Spark a Breakout for the Stock?
- Most Volatile Stocks, What Investors Need to Know
- S&P 500 and Nasdaq-100 Flashed Death Crosses—Should You Worry?
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Fundamentally Sound, These 5 Stocks Sold Off Anyway
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
